NO174877C - Fremgangsmåte for fremstilling av et legemiddel med antitumorvirkning - Google Patents

Fremgangsmåte for fremstilling av et legemiddel med antitumorvirkning

Info

Publication number
NO174877C
NO174877C NO873243A NO873243A NO174877C NO 174877 C NO174877 C NO 174877C NO 873243 A NO873243 A NO 873243A NO 873243 A NO873243 A NO 873243A NO 174877 C NO174877 C NO 174877C
Authority
NO
Norway
Prior art keywords
pct
drug
preparation
antitumor effect
sec
Prior art date
Application number
NO873243A
Other languages
English (en)
Norwegian (no)
Other versions
NO873243D0 (no
NO174877B (no
NO873243L (no
Inventor
Hansjoerg Eibl
Original Assignee
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft filed Critical Max Planck Gesellschaft
Publication of NO873243D0 publication Critical patent/NO873243D0/no
Publication of NO873243L publication Critical patent/NO873243L/no
Publication of NO174877B publication Critical patent/NO174877B/no
Publication of NO174877C publication Critical patent/NO174877C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/22—Amides of acids of phosphorus
    • C07F9/24—Esteramides
    • C07F9/2454—Esteramides the amide moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/2458—Esteramides the amide moiety containing a substituent or a structure which is considered as characteristic of aliphatic amines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Respiratory Apparatuses And Protective Means (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Medicinal Preparation (AREA)
  • Electrically Operated Instructional Devices (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO873243A 1985-12-04 1987-08-03 Fremgangsmåte for fremstilling av et legemiddel med antitumorvirkning NO174877C (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE3542893 1985-12-04
DE3606631 1986-02-28
PCT/EP1986/000705 WO1987003480A2 (en) 1985-12-04 1986-12-04 Medicament with anti-tumoral action containing hexadecylphosphocholine

Publications (4)

Publication Number Publication Date
NO873243D0 NO873243D0 (no) 1987-08-03
NO873243L NO873243L (no) 1987-10-02
NO174877B NO174877B (no) 1994-04-18
NO174877C true NO174877C (no) 1994-07-27

Family

ID=25838509

Family Applications (2)

Application Number Title Priority Date Filing Date
NO873243A NO174877C (no) 1985-12-04 1987-08-03 Fremgangsmåte for fremstilling av et legemiddel med antitumorvirkning
NO873244A NO175620C (no) 1985-12-04 1987-08-03 Fremgangsmåte for fremstilling av et antitumorvirksomt legemiddel

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO873244A NO175620C (no) 1985-12-04 1987-08-03 Fremgangsmåte for fremstilling av et antitumorvirksomt legemiddel

Country Status (15)

Country Link
US (2) US4837023A (pt)
EP (4) EP0230575A3 (pt)
JP (2) JPH0637393B2 (pt)
AT (2) ATE75608T1 (pt)
CA (2) CA1338627C (pt)
DE (4) DE3641491A1 (pt)
DK (2) DK172954B1 (pt)
ES (2) ES2032755T3 (pt)
FI (2) FI873364A0 (pt)
GR (2) GR3002487T3 (pt)
HU (2) HU208143B (pt)
IE (2) IE59778B1 (pt)
NO (2) NO174877C (pt)
PT (2) PT83873B (pt)
WO (2) WO1987003478A2 (pt)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5916884A (en) * 1985-12-04 1999-06-29 Max-Planck-Gesellschaft Zur Foederung Der Wissenschaften Compositions containing a mixture of phosphorus compounds and alkylglycerols
CA2001401A1 (en) * 1988-10-25 1990-04-25 Claude Piantadosi Quaternary amine containing ether or ester lipid derivatives and therapeutic compositions
ATE137973T1 (de) * 1989-08-10 1996-06-15 Sandoz Ag Phospholipide zur behandlung der multiplen sklerose
US5182271A (en) * 1989-08-10 1993-01-26 Sandoz Ltd. Thioether, keto-ester and alkyl phospholipids useful in treating multiple sclerosis
US5290769A (en) * 1989-09-27 1994-03-01 Asta Pharma Aktiengesellschaft Use of hexadecylphosphocholine for the treatment of psoriasis
EP0916343A1 (de) * 1989-09-27 1999-05-19 ASTA Medica Aktiengesellschaft Verwendung von Alkylphosphorsäure-Verbindungen zur Bekämpfung von Psoriasis-Erkrankungen
DE4111105A1 (de) * 1991-04-05 1992-10-08 Max Planck Gesellschaft Neue erucyl-, brassidyl- und nervonylderivate
US5506217A (en) * 1991-04-25 1996-04-09 The University Of British Columbia Phosphonates as anti-cancer agents
US5369097A (en) * 1991-04-25 1994-11-29 The University Of British Columbia Phosphonates as anti-cancer agents
ES2108715T3 (es) * 1991-07-04 1998-01-01 Asta Medica Ag Procedimiento para la preparacion de alquilfosfocolinas y purificacion de las mismas.
DE4132344A1 (de) * 1991-09-27 1993-04-01 Max Planck Gesellschaft Verfahren zur herstellung eines arzneimittels zur oralen oder topischen verabreichung bei der behandlung von leishmaniasis
US6254879B1 (en) 1991-09-27 2001-07-03 Max-Planck-Gessellschaft zun Förderung der Wissenschaften e.V. Methods of treating protozoal diseases
US5298655A (en) * 1991-09-27 1994-03-29 Merck & Co., Inc. Farnesyl pyrophosphate analogs
DE4222910A1 (de) * 1992-07-11 1994-01-13 Asta Medica Ag Neue Phospholipidderivate
US6172050B1 (en) 1992-07-11 2001-01-09 Asta Medica Aktiengesellschaft Phospholipid derivatives
DE4235911A1 (de) * 1992-10-23 1994-04-28 Asta Medica Ag Stabilisierte Hexadecylphosphocholinlösungen in Glycerinalkylethern
DE69431596D1 (de) * 1993-06-10 2002-11-28 Wake Forest University Winston (phospho)lipide zum bekämpfen einer hepatitis b-infektion
US6551623B1 (en) 1993-09-09 2003-04-22 Lorus Therapeutics Inc. Immunomodulating compositions from bile
EP0717631B1 (en) 1993-09-09 2003-07-09 Lorus Therapeutics Inc. Immunomodulating compositions from bile
US7135584B2 (en) * 1995-08-07 2006-11-14 Wake Forest University Lipid analogs for treating viral infections
AU3216695A (en) * 1994-08-29 1996-03-22 University Of North Carolina At Chapel Hill, The Lipid analogs for treating viral infections
US5574025A (en) * 1994-10-26 1996-11-12 Merck & Co., Inc. Inhibitors of prenyl-protein transferases
WO1996024598A1 (en) * 1995-02-10 1996-08-15 The University Of British Columbia [4-hexadecyl-3-methoxy-butyl] phosphonic acid and its protein conjugates useful as anti-cancer agents
AU711294B2 (en) 1995-03-16 1999-10-07 Erin Mills Biotech Inc. Immunomodulating compositions from bile for the treatment of immune system disorders
KR100499190B1 (ko) * 1996-03-29 2006-04-17 교와 핫꼬 고교 가부시끼가이샤 육모제
US20040101569A1 (en) * 1996-05-16 2004-05-27 Lorus Therapeutics Inc. Immunomodulating compositions from bile
US6121245A (en) * 1997-01-29 2000-09-19 Firshein; Richard N. Method of treating cancer using alkylglycerols in conjunction with chemotherapy
SE9701912D0 (sv) * 1997-05-22 1997-05-22 Interhealth Ab Pharmaceutical composition and use thereof
US7582678B2 (en) * 1997-07-09 2009-09-01 D-Pharm Limited Use of branched-chain fatty acids and derivatives thereof for the treatment of pain
ATE215817T1 (de) * 1998-01-22 2002-04-15 Zentaris Ag Feste miltefosin enthaltende arzneimittel zur oralen verabreichung bei der behandlung von leishmaniasis
US7026469B2 (en) * 2000-10-19 2006-04-11 Wake Forest University School Of Medicine Compositions and methods of double-targeting virus infections and cancer cells
IL137672A0 (en) 2000-08-03 2001-10-31 Dpharm Ltd Derivatives of branched-chain lipophilic molecules and uses thereof
US7309696B2 (en) 2000-10-19 2007-12-18 Wake Forest University Compositions and methods for targeting cancer cells
EP1397326A2 (en) * 2001-05-29 2004-03-17 Koninklijke Philips Electronics N.V. Metal-ceramic bond
WO2003021959A1 (en) * 2001-08-31 2003-03-13 Thomson Licensing Sa Sequence counter for an audio visual stream
BR0215680A (pt) * 2002-04-26 2005-02-01 Rudolf Perl Composição farmacêutica oral estável
US20050187191A1 (en) * 2004-02-20 2005-08-25 Kucera Louis S. Methods and compositions for the treatment of respiratory syncytial virus
CA2632449A1 (en) 2005-12-19 2007-06-28 Aeterna Zentaris Gmbh Alkyl phospholipid derivatives with reduced cytotoxicity and uses thereof
ES2391226T3 (es) * 2006-12-20 2012-11-22 Alphaptose Gmbh Forma farmacéutica tópica que comprende compuestos de glicerol tri-sustituido
JP2011057647A (ja) * 2009-09-14 2011-03-24 Adeka Corp 化粧料
CN103732231B (zh) 2011-06-24 2020-04-10 格里生物公司 炎性病症的预防和治疗
CN102491994B (zh) * 2011-12-07 2014-10-15 宁波九胜创新医药科技有限公司 一种胆碱磷酸烷基酯的制备方法
CN114712504A (zh) * 2014-12-09 2022-07-08 Gri生物有限公司 炎性病况的预防和治疗

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3225227A1 (de) * 1982-07-06 1984-01-12 Max Planck Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Derivate des n.n-bis-(2-chlor-aethyl)-phosphorsaeureamids
JPS5984824A (ja) * 1982-11-08 1984-05-16 Takeda Chem Ind Ltd 抗腫瘍剤
US4690935A (en) * 1983-03-31 1987-09-01 Wayne State University Inhibition of tumor growth and metastasis with calcium channel blocker compounds

Also Published As

Publication number Publication date
DK398587D0 (da) 1987-07-30
JPH0859677A (ja) 1996-03-05
EP0248047A1 (de) 1987-12-09
EP0248062A1 (de) 1987-12-09
CA1280369C (en) 1991-02-19
DK393187D0 (da) 1987-07-28
DK393187A (da) 1987-07-28
NO873244L (no) 1987-10-01
NO873243D0 (no) 1987-08-03
WO1987003478A3 (fr) 1987-09-24
EP0248062B1 (de) 1992-05-06
HU203201B (en) 1991-06-28
ATE64529T1 (de) 1991-07-15
PT83872A (de) 1987-01-01
FI873363A (fi) 1987-08-03
EP0230575A3 (de) 1987-12-02
GR3002487T3 (en) 1992-12-30
FI873363A0 (fi) 1987-08-03
NO174877B (no) 1994-04-18
HUT44441A (en) 1988-03-28
IE59778B1 (en) 1994-04-06
NO873243L (no) 1987-10-02
EP0225608A3 (de) 1987-10-28
EP0230575A2 (de) 1987-08-05
JP2857084B2 (ja) 1999-02-10
IE59777B1 (en) 1994-04-06
DK398587A (da) 1987-07-30
DE3641379A1 (de) 1987-09-03
DK172954B1 (da) 1999-10-18
WO1987003480A2 (en) 1987-06-18
DE3641491A1 (de) 1987-09-17
FI873364A (fi) 1987-08-03
CA1338627C (en) 1996-10-01
US4837023A (en) 1989-06-06
EP0225608A2 (de) 1987-06-16
NO175620B (pt) 1994-08-01
NO175620C (no) 1994-11-09
WO1987003478A2 (fr) 1987-06-18
HUT44431A (en) 1988-03-28
GR3005168T3 (pt) 1993-05-24
IE863177L (en) 1987-06-04
ES2032755T3 (es) 1993-03-01
DE3679908D1 (de) 1991-07-25
JPH0637393B2 (ja) 1994-05-18
FI873364A0 (fi) 1987-08-03
ATE75608T1 (de) 1992-05-15
HU208143B (en) 1993-08-30
ES2038215T3 (es) 1993-07-16
PT83873B (pt) 1989-01-17
NO873244D0 (no) 1987-08-03
EP0248047B1 (de) 1991-06-19
JPS63501719A (ja) 1988-07-14
PT83872B (pt) 1989-01-17
IE863176L (en) 1987-06-04
US5049552A (en) 1991-09-17
PT83873A (de) 1987-01-01
DE19375061I2 (de) 2008-11-20
WO1987003480A3 (fr) 1988-02-25

Similar Documents

Publication Publication Date Title
NO174877C (no) Fremgangsmåte for fremstilling av et legemiddel med antitumorvirkning
FI881978A0 (fi) Menetelmä eperisonia sisältävän farmaseuttisen koostumuksen valmistamiseksi
IL67697A (en) 6-substituted-s-triazolo(3,4-a)phthalazine derivatives,their preparation and pharmaceutical compositions containing them
ZA848369B (en) Pharmaceutical compositions containing bilobalid for the treatment of neuropathies
ES525786A0 (es) Un procedimiento para preparar derivados de pirazolo (3,4-b) piridina
NO167570C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive flavonforbindelser.
PT87301A (pt) Process for the preparation of 1,3-dioxanes by products and of pharmaceutical compounds containing them
YU49079B (sh) Novi derivati fosfolipida i postupak za njihovu proizvodnju
DE3378120D1 (en) Thiazaspiro derivatives, process for their preparation and pharmaceutical composition
NO170331C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive acyleringsprodukter av bis(2-imidazolin-2-ylhydrazoner)av 9,10-antracen- dikarboksaldehyd
OA08184A (fr) Agents anti-hypertentifs, compositions pharmaceutiques les contenant et procédé de préparation desdits agents et compositions.
DK311284D0 (da) 3-(4'-aminobutylamino)-propylamino-bleomycin-derivater, deres fremstilling og deres anvendelse som laegemidler

Legal Events

Date Code Title Description
MK1K Patent expired